Cargando…

The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease

OBJECTIVE: Recent genome-wide association studies have established that polymorphisms within CDKN2B-AS1 of chr9p21.3 locus increased susceptibility to coronary artery disease (CAD) or myocardial infarction. Common variants of CDKN2B-AS1 (including rs4977574 A>G and rs1333040 C>T) are determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Temel, Şehime Gülsün, Ergören, Mahmut Çerkez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382903/
https://www.ncbi.nlm.nih.gov/pubmed/30587704
http://dx.doi.org/10.14744/AnatolJCardiol.2018.90907
_version_ 1783396745871360000
author Temel, Şehime Gülsün
Ergören, Mahmut Çerkez
author_facet Temel, Şehime Gülsün
Ergören, Mahmut Çerkez
author_sort Temel, Şehime Gülsün
collection PubMed
description OBJECTIVE: Recent genome-wide association studies have established that polymorphisms within CDKN2B-AS1 of chr9p21.3 locus increased susceptibility to coronary artery disease (CAD) or myocardial infarction. Common variants of CDKN2B-AS1 (including rs4977574 A>G and rs1333040 C>T) are determined to be directly associated with CADs in many populations worldwide and suggested biomarkers for the early detection of CAD. There is a lack of investigation for the association between CDKN2B-AS1 rs4977574 A>G and rs1333040 C>T genetic modifiers and CAD in a Turkish Cypriot population. The aim of the present study was to investigate the potential effects of these variants on susceptibility to developing CAD in a Turkish Cypriot population and their contribution to lipid metabolism. METHODS: Seventy-one patients with angiography-confirmed CAD were recruited to the CAD group, whereas 153 voluntary subjects without CAD symptoms were enrolled to the control group. Genotyping for the CDKN2B-AS1 gene polymorphisms was performed by polymerase chain reaction, followed by restriction fragment length polymorphism analysis. RESULTS: There is no statistical significant association observed between rs4977574 and rs1333040 single-nucleotide polymorphisms and two studied groups [odds ratio (OR): 0.763, p=0.185, 95% confidence interval (CI): 0.511–1.139 and OR: 1.060, p=0.802, 95% CI 0.672–1.671, respectively]. However, rs2977574 G and rs1333040 T alleles–the risk alleles–were found to be associated with higher level of serum total cholesterol and lower level of high-density lipoprotein-cholesterol in the CAD group (p=0.019, p=0.006 and p=0.022, p=0.031, respectively). To our knowledge, this is the first study that establishes the effect of rs1333040 on lipid metabolism. CONCLUSION: The presence of rs4977574 G and rs1333040 T alleles and interaction may exist as environmental factors associated with lipid metabolism and might be responsible for the development of CAD in a Turkish Cypriot population.
format Online
Article
Text
id pubmed-6382903
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-63829032019-02-27 The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease Temel, Şehime Gülsün Ergören, Mahmut Çerkez Anatol J Cardiol Original Investigation OBJECTIVE: Recent genome-wide association studies have established that polymorphisms within CDKN2B-AS1 of chr9p21.3 locus increased susceptibility to coronary artery disease (CAD) or myocardial infarction. Common variants of CDKN2B-AS1 (including rs4977574 A>G and rs1333040 C>T) are determined to be directly associated with CADs in many populations worldwide and suggested biomarkers for the early detection of CAD. There is a lack of investigation for the association between CDKN2B-AS1 rs4977574 A>G and rs1333040 C>T genetic modifiers and CAD in a Turkish Cypriot population. The aim of the present study was to investigate the potential effects of these variants on susceptibility to developing CAD in a Turkish Cypriot population and their contribution to lipid metabolism. METHODS: Seventy-one patients with angiography-confirmed CAD were recruited to the CAD group, whereas 153 voluntary subjects without CAD symptoms were enrolled to the control group. Genotyping for the CDKN2B-AS1 gene polymorphisms was performed by polymerase chain reaction, followed by restriction fragment length polymorphism analysis. RESULTS: There is no statistical significant association observed between rs4977574 and rs1333040 single-nucleotide polymorphisms and two studied groups [odds ratio (OR): 0.763, p=0.185, 95% confidence interval (CI): 0.511–1.139 and OR: 1.060, p=0.802, 95% CI 0.672–1.671, respectively]. However, rs2977574 G and rs1333040 T alleles–the risk alleles–were found to be associated with higher level of serum total cholesterol and lower level of high-density lipoprotein-cholesterol in the CAD group (p=0.019, p=0.006 and p=0.022, p=0.031, respectively). To our knowledge, this is the first study that establishes the effect of rs1333040 on lipid metabolism. CONCLUSION: The presence of rs4977574 G and rs1333040 T alleles and interaction may exist as environmental factors associated with lipid metabolism and might be responsible for the development of CAD in a Turkish Cypriot population. Kare Publishing 2019-01 2018-12-07 /pmc/articles/PMC6382903/ /pubmed/30587704 http://dx.doi.org/10.14744/AnatolJCardiol.2018.90907 Text en Copyright: © 2018 Turkish Society of Cardiology http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Original Investigation
Temel, Şehime Gülsün
Ergören, Mahmut Çerkez
The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease
title The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease
title_full The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease
title_fullStr The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease
title_full_unstemmed The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease
title_short The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease
title_sort association between the chromosome 9p21 cdkn2b-as1 gene variants and the lipid metabolism: a pre-diagnostic biomarker for coronary artery disease
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382903/
https://www.ncbi.nlm.nih.gov/pubmed/30587704
http://dx.doi.org/10.14744/AnatolJCardiol.2018.90907
work_keys_str_mv AT temelsehimegulsun theassociationbetweenthechromosome9p21cdkn2bas1genevariantsandthelipidmetabolismaprediagnosticbiomarkerforcoronaryarterydisease
AT ergorenmahmutcerkez theassociationbetweenthechromosome9p21cdkn2bas1genevariantsandthelipidmetabolismaprediagnosticbiomarkerforcoronaryarterydisease
AT temelsehimegulsun associationbetweenthechromosome9p21cdkn2bas1genevariantsandthelipidmetabolismaprediagnosticbiomarkerforcoronaryarterydisease
AT ergorenmahmutcerkez associationbetweenthechromosome9p21cdkn2bas1genevariantsandthelipidmetabolismaprediagnosticbiomarkerforcoronaryarterydisease